back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-04-02 17:30 Tx date 2024-03-29 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,553 vol |
20,452 | |
| Filed 2024-01-03 21:41 Tx date 2023-12-29 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,575 vol |
18,899 | |
| Filed 2023-10-03 21:03 Tx date 2023-09-29 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,585 vol |
17,324 | |
| Filed 2023-07-05 16:11 Tx date 2023-06-30 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,339 vol |
15,739 | |
| Filed 2023-07-05 15:26 Tx date 2023-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$12,776
+1,597 vol $8.00 each |
94,147 | |
| Filed 2023-05-08 10:04 Tx date 2023-05-04 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,857 vol |
14,400 | |
| Filed 2023-04-27 16:54 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$214,000
+12,500 vol $17.12 each |
12,500 | |
| Filed 2023-04-27 16:54 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-04-27 16:54 Tx date 2023-04-24 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
$-214,000
-12,500 vol $17.12 each |
1,543 | |
| Filed 2023-04-05 12:33 Tx date 2023-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$29,500
+3,642 vol $8.10 each |
92,550 | |
| Filed 2023-04-04 17:10 Tx date 2023-03-31 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+1,543 vol |
14,043 | |
| Filed 2023-01-04 16:57 Tx date 2022-12-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$32,568
+5,186 vol $6.28 each |
88,908 | |
| Filed 2022-10-04 16:28 Tx date 2022-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,374
+4,989 vol $6.89 each |
83,722 | |
| Filed 2022-07-06 14:42 Tx date 2022-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,367
+4,111 vol $8.36 each |
78,733 | |
| Filed 2022-06-29 12:49 Tx date 2022-06-24 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+34,387 vol |
74,622 | |
| Filed 2022-05-12 10:48 Tx date 2022-05-10 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+12,500 vol |
12,500 | |
| Filed 2022-05-12 10:48 Tx date 2022-05-05 |
$BLCO
Bausch + Lomb Corporation |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-04-05 11:57 Tx date 2022-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,366
+1,504 vol $22.85 each |
40,235 | |
| Filed 2022-01-04 13:03 Tx date 2021-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,245 vol |
38,731 | |
| Filed 2021-10-04 18:16 Tx date 2021-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,366
+1,234 vol $27.85 each |
37,486 | |
| Filed 2021-08-06 16:54 Tx date 2021-08-04 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$250,123
+10,000 vol $25.01 each |
280,857 | |
| Filed 2021-07-05 11:17 Tx date 2021-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$34,363
+1,172 vol $29.32 each |
36,252 | |
| Filed 2021-05-03 19:39 Tx date 2021-04-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,991
+7,645 vol $32.70 each |
35,080 | |
| Filed 2021-04-30 17:41 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$344,906
+11,037 vol $31.25 each |
270,857 | |
| Filed 2021-04-30 17:40 Tx date 2021-04-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,037 vol |
27,435 | |
| Filed 2021-04-05 13:00 Tx date 2021-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,961
+1,070 vol $31.74 each |
38,472 | |
| Filed 2021-01-07 12:10 Tx date 2020-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,737
+1,622 vol $20.80 each |
37,402 | |
| Filed 2020-10-05 13:05 Tx date 2020-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$33,737
+2,171 vol $15.54 each |
35,780 | |
| Filed 2020-07-03 11:43 Tx date 2020-06-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$32,007
+1,750 vol $18.29 each |
33,609 | |
| Filed 2020-05-04 10:46 Tx date 2020-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+11,037 vol |
31,859 | |
| Filed 2020-05-04 10:43 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-11,300.64
-624 vol $18.11 each |
259,820 | |
| Filed 2020-05-04 10:43 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$192,563
+10,633 vol $18.11 each |
260,444 | |
| Filed 2020-05-04 10:42 Tx date 2020-04-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-10,633 vol |
20,822 | |
| Filed 2020-04-02 17:53 Tx date 2020-03-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,248
+2,016 vol $15.50 each |
31,455 | |
| Filed 2020-03-12 09:44 Tx date 2020-03-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$69,377
+3,800 vol $18.26 each |
13,800 | |
| Filed 2020-03-12 09:44 Tx date 2017-01-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2020-03-12 09:42 Tx date 2020-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$115,414
+5,000 vol $23.08 each |
249,811 | |
| Filed 2020-01-03 12:22 Tx date 2019-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,236
+1,044 vol $29.92 each |
29,439 | |
| Filed 2019-10-04 17:24 Tx date 2019-09-30 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,245
+1,430 vol $21.85 each |
28,395 | |
| Filed 2019-07-05 16:09 Tx date 2019-06-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,247
+1,239 vol $25.22 each |
26,965 | |
| Filed 2019-05-06 11:30 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-94,425.48
-3,996 vol $23.63 each |
244,811 | |
| Filed 2019-05-06 11:28 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$328,008
+13,881 vol $23.63 each |
248,807 | |
| Filed 2019-05-06 11:28 Tx date 2019-05-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-13,881 vol |
15,093 | |
| Filed 2019-05-06 11:26 Tx date 2019-05-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$249,981
+10,633 vol $23.51 each |
25,726 | |
| Filed 2019-04-12 10:22 Tx date 2019-03-29 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,265 vol |
28,974 | |
| Filed 2019-01-07 Tx date 2018-12-31 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,232
+1,691 vol $18.47 each |
27,709 | |
| Filed 2018-10-03 Tx date 2018-09-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,217 vol |
26,018 | |
| Filed 2018-09-18 Tx date 2018-09-13 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,995,000
+125,000 vol $23.96 each |
234,926 | |
| Filed 2018-07-06 Tx date 2018-06-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,234
+1,344 vol $23.24 each |
24,801 | |
| Filed 2018-05-18 Tx date 2018-05-15 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$327,450
+15,000 vol $21.83 each |
109,926 | |
| Filed 2018-05-11 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-25,406 vol |
23,457 | |
| Filed 2018-05-11 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-63,642.54
-3,522 vol $18.07 each |
94,926 | |
| Filed 2018-05-11 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$459,086
+25,406 vol $18.07 each |
98,448 | |
| Filed 2018-05-10 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+13,881 vol |
48,863 | |
| Filed 2018-05-10 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
||
| Filed 2018-05-04 Tx date 2018-05-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+14,285 vol |
49,267 | |
| Filed 2018-04-06 Tx date 2018-03-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,235
+1,962 vol $15.92 each |
34,982 | |
| Filed 2018-03-14 Tx date 2018-03-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$153,400
+10,000 vol $15.34 each |
73,042 | |
| Filed 2018-01-03 Tx date 2017-12-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+1,503 vol |
33,020 | |
| Filed 2017-11-21 Tx date 2017-11-17 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$143,300
+10,000 vol $14.33 each |
63,042 | |
| Filed 2017-10-04 Tx date 2017-09-29 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,239
+2,180 vol $14.33 each |
31,517 | |
| Filed 2017-08-24 Tx date 2017-08-21 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$70,315
+4,900 vol $14.35 each |
53,042 | |
| Filed 2017-08-24 Tx date 2017-08-21 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$72,981
+5,100 vol $14.31 each |
48,142 | |
| Filed 2017-07-06 Tx date 2017-06-30 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$31,261
+1,807 vol $17.30 each |
29,337 | |
| Filed 2017-05-15 Tx date 2017-05-11 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$278,000
+20,000 vol $13.90 each |
43,042 | |
| Filed 2017-05-09 Tx date 2017-05-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-11,190 vol |
27,530 | |
| Filed 2017-05-09 Tx date 2017-05-05 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+25,406 vol |
38,720 | |
| Filed 2017-05-09 Tx date 2017-05-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-20,749.68
-2,148 vol $9.66 each |
23,042 | |
| Filed 2017-05-09 Tx date 2017-05-08 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$108,095
+11,190 vol $9.66 each |
25,190 | |
| Filed 2017-04-10 Tx date 2017-03-31 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$23,427
+2,124 vol $11.03 each |
13,314 | |
| Filed 2017-03-18 Tx date 2017-03-15 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$108,000
+10,000 vol $10.80 each |
14,000 | |
| Filed 2017-01-06 Tx date 2017-01-03 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$170,535
+11,190 vol $15.24 each |
11,190 | |
| Filed 2017-01-06 Tx date 2017-01-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-01-06 Tx date 2017-01-01 |
$VRX
Valeant Pharmaceuticals International, Inc. |
DE SCHUTTER, Richard Urbain
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
4,000 |